Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relapse Prevention of Bipolar Type-II Disorder
NCT00044616Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2001
- Primary completion
- Jan 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine, lithium in Bipolar II disorder (BP-II), sponsored by University of Pennsylvania. Started Feb 2001; status: completed.
02
Drugs
fluoxetinelithium
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00044616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044616.